Tirzepatide represents a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://lexiemrgl864100.techionblog.com/40802660/tirzepatide-a-new-frontier-in-diabetes-treatment